"Inauguré en 2012, l'Hôpital privé de Villeneuve d'Ascq est issu du regroupement de la clinique du parc et de la maternité de Villeneuve d'Ascq (ex clinique Cotteel). Des synergies fortes sont développées entre les deux établissements du Pôle Lille Métropole du groupe Ramsay Santé, constitué de l'Hôpital privé de Villeneuve d’Ascq et de l'Hôpital privé la Louvière, afin de vous garantir une prise en charge pluridisciplinaire."

During the past decade, Hôpital Privé de VILLENEUVE D'ASCQ conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Privé de VILLENEUVE D'ASCQ" #1 sponsor was "Centre Oscar Lambret" with 2 trials, followed by "Federation Francophone de Cancerologie Digestive" with 2 trials sponsored, "Hospices Civils de Lyon" with 1 trials sponsored, "UNICANCER" with 1 trials sponsored and "Vascutek Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Privé de VILLENEUVE D'ASCQ" #1 collaborator was "Aix Marseille Université" with 1 trials as a collaborator, "Canceropôle Nord Ouest" with 1 trials as a collaborator, "Federation of Medical Specialties" with 1 trials as a collaborator, "HalioDx" with 1 trials as a collaborator and "National Cancer Institute, France" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Privé de VILLENEUVE D'ASCQ" are "Breast Cancer" (2 trials), "Aging" (1 trials), "Aneurysm" (1 trials), "Colonic Neoplasms" (1 trials) and "Colorectal Neoplasms" (1 trials). Many other conditions were trialed in "Hôpital Privé de VILLENEUVE D'ASCQ" in a lesser frequency.

Most popular intervention types in "Hôpital Privé de VILLENEUVE D'ASCQ" are "Behavioral" (2 trials), "Drug" (2 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "LV5FU2" (2 trials), "Delivery of questionnaires" (1 trials), "FOLFIRI.3" (1 trials), "FOLFIRINOX" (1 trials) and "Fenestrated Anaconda™ Device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Privé de VILLENEUVE D'ASCQ" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hôpital Privé de VILLENEUVE D'ASCQ". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hôpital Privé de VILLENEUVE D'ASCQ, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Privé de VILLENEUVE D'ASCQ, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".